Format

Send to

Choose Destination
Curr Opin Microbiol. 2013 Aug;16(4):398-403. doi: 10.1016/j.mib.2013.03.007. Epub 2013 Apr 6.

Candida albicans biofilms: building a heterogeneous, drug-tolerant environment.

Author information

1
Université de Caen Basse-Normandie EA 4655, U2RM, CHU Côte de Nacre, F-14033 Caen, France.

Abstract

Fungi are able to form biofilms on medical implants, causing serious infections. A better understanding of fungal biofilm formation is necessary to develop tools for detection or prevention and to identify new antifungal strategies. This review explores recent advances in the characterization at the molecular level of fungal biofilms, especially those formed by the yeast Candida albicans: the identification of complex transcriptional networks that control their formation; the pivotal role of the extracellular matrix in biofilm antifungal tolerance; and the knowledge gained on the physiology of biofilm cells and heterogeneity within these communities. These findings may help develop new, targeted therapeutic strategies.

PMID:
23566895
DOI:
10.1016/j.mib.2013.03.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center